BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 16281057)

  • 1. SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways.
    Huang J; Liu T; Xu LG; Chen D; Zhai Z; Shu HB
    EMBO J; 2005 Dec; 24(23):4018-28. PubMed ID: 16281057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways.
    Han KJ; Su X; Xu LG; Bin LH; Zhang J; Shu HB
    J Biol Chem; 2004 Apr; 279(15):15652-61. PubMed ID: 14739303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter.
    Wang YY; Li L; Han KJ; Zhai Z; Shu HB
    FEBS Lett; 2004 Oct; 576(1-2):86-90. PubMed ID: 15474016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.
    tenOever BR; Sharma S; Zou W; Sun Q; Grandvaux N; Julkunen I; Hemmi H; Yamamoto M; Akira S; Yeh WC; Lin R; Hiscott J
    J Virol; 2004 Oct; 78(19):10636-49. PubMed ID: 15367631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of a TIR-less splice variant of TRIF reveals an unexpected mechanism of TLR3-mediated signaling.
    Han KJ; Yang Y; Xu LG; Shu HB
    J Biol Chem; 2010 Apr; 285(17):12543-50. PubMed ID: 20200155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.
    Sato S; Sugiyama M; Yamamoto M; Watanabe Y; Kawai T; Takeda K; Akira S
    J Immunol; 2003 Oct; 171(8):4304-10. PubMed ID: 14530355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter organization of the interferon-A genes differentially affects virus-induced expression and responsiveness to TBK1 and IKKepsilon.
    Civas A; Génin P; Morin P; Lin R; Hiscott J
    J Biol Chem; 2006 Feb; 281(8):4856-66. PubMed ID: 16380379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A20 is a negative regulator of IFN regulatory factor 3 signaling.
    Saitoh T; Yamamoto M; Miyagishi M; Taira K; Nakanishi M; Fujita T; Akira S; Yamamoto N; Yamaoka S
    J Immunol; 2005 Feb; 174(3):1507-12. PubMed ID: 15661910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming Phosphorylation of TANK-Binding Kinase 1 by IκB Kinase β Is Essential in Toll-Like Receptor 3/4 Signaling.
    Abe H; Satoh J; Shirasaka Y; Kogure A; Kato H; Ito S; Fujita T
    Mol Cell Biol; 2020 Feb; 40(5):. PubMed ID: 31818880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR3/TRIF signalling pathway regulates IL-32 and IFN-β secretion through activation of RIP-1 and TRAF in the human cornea.
    Park GB; Hur DY; Kim YS; Lee HK; Yang JW; Kim D
    J Cell Mol Med; 2015 May; 19(5):1042-54. PubMed ID: 25754842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
    Jiang Z; Mak TW; Sen G; Li X
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VISA is an adapter protein required for virus-triggered IFN-beta signaling.
    Xu LG; Wang YY; Han KJ; Li LY; Zhai Z; Shu HB
    Mol Cell; 2005 Sep; 19(6):727-40. PubMed ID: 16153868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.
    Yu S; Chen J; Wu M; Chen H; Kato N; Yuan Z
    J Gen Virol; 2010 Aug; 91(Pt 8):2080-2090. PubMed ID: 20375222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.
    Paz S; Sun Q; Nakhaei P; Romieu-Mourez R; Goubau D; Julkunen I; Lin R; Hiscott J
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):17-28. PubMed ID: 16914100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of endogenous regulation of the type I interferon response by suppressor of IκB kinase epsilon (SIKE), a novel substrate of TANK-binding kinase 1 (TBK1).
    Marion JD; Roberts CF; Call RJ; Forbes JL; Nelson KT; Bell JE; Bell JK
    J Biol Chem; 2013 Jun; 288(25):18612-23. PubMed ID: 23649622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of TBK1 and IKKε in the expression and activation of Pellino 1.
    Smith H; Liu XY; Dai L; Goh ET; Chan AT; Xi J; Seh CC; Qureshi IA; Lescar J; Ruedl C; Gourlay R; Morton S; Hough J; McIver EG; Cohen P; Cheung PC
    Biochem J; 2011 Mar; 434(3):537-48. PubMed ID: 21204785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation.
    Schröder M; Baran M; Bowie AG
    EMBO J; 2008 Aug; 27(15):2147-57. PubMed ID: 18636090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection.
    Ito M; Masumi A; Mochida K; Kukihara H; Moriishi K; Matsuura Y; Yamaguchi K; Mizuochi T
    J Innate Immun; 2010; 2(6):607-17. PubMed ID: 20714117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase Calpha is involved in interferon regulatory factor 3 activation and type I interferon-beta synthesis.
    Johnson J; Albarani V; Nguyen M; Goldman M; Willems F; Aksoy E
    J Biol Chem; 2007 May; 282(20):15022-32. PubMed ID: 17296604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.
    Fitzgerald KA; McWhirter SM; Faia KL; Rowe DC; Latz E; Golenbock DT; Coyle AJ; Liao SM; Maniatis T
    Nat Immunol; 2003 May; 4(5):491-6. PubMed ID: 12692549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.